BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31301917)

  • 1. Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Islam MT; Chowdhury F; Qadri F; Sur D; Ganguly NK
    Vaccine; 2020 Feb; 38 Suppl 1():A127-A131. PubMed ID: 31301917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
    Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
    Chowdhury F; Akter A; Bhuiyan TR; Tauheed I; Teshome S; Sil A; Park JY; Chon Y; Ferdous J; Basher SR; Ahmed F; Karim M; Ahasan MM; Mia MR; Masud MMI; Khan AW; Billah M; Nahar Z; Khan I; Ross AG; Kim DR; Ashik MMR; Digilio L; Lynch J; Excler JL; Clemens JD; Qadri F
    Vaccine; 2022 Jan; 40(4):640-649. PubMed ID: 34969541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
    Chowdhury F; Ali Syed K; Akter A; Rahman Bhuiyan T; Tauheed I; Khaton F; Biswas R; Ferdous J; Al Banna H; Ross AG; Mc Millan N; Sharma T; Kanchan V; Pal Singh A; Gill D; Lebens M; Nordqvist S; Holmgren J; Clemens JD; Qadri F
    Vaccine; 2021 Jul; 39(32):4450-4457. PubMed ID: 34218960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
    Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
    Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Hossain M; Tauheed I; Ahmed T; Islam S; Rafique TA; Siddique SA; Harun NB; Islam K; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007989. PubMed ID: 32176695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.
    Kanungo S; Desai SN; Saha J; Nandy RK; Sinha A; Kim DR; Bannerjee B; Manna B; Yang JS; Ali M; Sur D; Wierzba TF
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003809. PubMed ID: 26023778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
    Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
    Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
    Charles RC; Hilaire IJ; Mayo-Smith LM; Teng JE; Jerome JG; Franke MF; Saha A; Yu Y; Kováč P; Calderwood SB; Ryan ET; LaRocque RC; Almazor CP; Qadri F; Ivers LC; Harris JB
    PLoS Negl Trop Dis; 2014 May; 8(5):e2828. PubMed ID: 24786645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
    Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
    Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh.
    Khan IA; Khan AI; Rahman A; Siddique SA; Islam MT; Bhuiyan MAI; Chowdhury AI; Saha NC; Biswas PK; Saha A; Chowdhury F; Clemens JD; Qadri F
    Glob Health Action; 2019; 12(1):1574544. PubMed ID: 30764750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia.
    Desai SN; Akalu Z; Teshome S; Teferi M; Yamuah L; Kim DR; Yang JS; Hussein J; Park JY; Jang MS; Mesganaw C; Taye H; Beyene D; Bedru A; Singh AP; Wierzba TF; Aseffa A
    Am J Trop Med Hyg; 2015 Sep; 93(3):527-533. PubMed ID: 26078323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.
    Chowdhury F; Aziz AB; Ahmmed F; Ahmed T; Kang SS; Im J; Park J; Tadesse BT; Islam MT; Kim DR; Hoque M; Pak G; Khanam F; McMillan NAJ; Liu X; Zaman K; Khan AI; Kim JH; Marks F; Qadri F; Clemens JD
    Vaccine; 2023 Mar; 41(14):2368-2375. PubMed ID: 36898931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
    Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
    Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.